Global Diclofenac Patches 麻豆原创 Research Report 2024

Publication ID:

PB503248270

Publication Date:

March 13, 2024

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Healthcare [2]

Pharma & Healthcare [3]

Description:

The global Diclofenac Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Diclofenac Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Diclofenac Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Diclofenac Patches include Acorda Therapeutics, Endo International, GlaxoSmithKline, Hisamitsu Pharmaceutical, Mylan, Pfizer, Teikoku Seiyaku, IBSA Institut Biochimque and TEH SENG Pharmaceutical, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Diclofenac Patches, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Diclofenac Patches.
Report Scope
The Diclofenac Patches market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Diclofenac Patches market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Diclofenac Patches manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
麻豆原创 Segmentation
By Company
Acorda Therapeutics
Endo International
GlaxoSmithKline
Hisamitsu Pharmaceutical
Mylan
Pfizer
Teikoku Seiyaku
IBSA Institut Biochimque
TEH SENG Pharmaceutical
ALLERGAN
Segment by Type
Polyisobutylene
Polyacrylate
Silicone Rubber
Other
Segment by Application
Hospital Pharmacies
Online Pharmacies
Independent Pharmacies & Drug Stores
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Diclofenac Patches manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Diclofenac Patches in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Diclofenac Patches 麻豆原创 Overview
1.1 Product Overview and Scope of Diclofenac Patches
1.2 Diclofenac Patches Segment by Type
1.2.1 Global Diclofenac Patches 麻豆原创 Value Comparison by Type (2024-2030)
1.2.2 Polyisobutylene
1.2.3 Polyacrylate
1.2.4 Silicone Rubber
1.2.5 Other
1.3 Diclofenac Patches Segment by Application
1.3.1 Global Diclofenac Patches 麻豆原创 Value by Application: (2024-2030)
1.3.2 Hospital Pharmacies
1.3.3 Online Pharmacies
1.3.4 Independent Pharmacies & Drug Stores
1.4 Global Diclofenac Patches 麻豆原创 Size Estimates and Forecasts
1.4.1 Global Diclofenac Patches Revenue 2019-2030
1.4.2 Global Diclofenac Patches Sales 2019-2030
1.4.3 Global Diclofenac Patches 麻豆原创 Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Diclofenac Patches 麻豆原创 Competition by Manufacturers
2.1 Global Diclofenac Patches Sales 麻豆原创 Share by Manufacturers (2019-2024)
2.2 Global Diclofenac Patches Revenue 麻豆原创 Share by Manufacturers (2019-2024)
2.3 Global Diclofenac Patches Average Price by Manufacturers (2019-2024)
2.4 Global Diclofenac Patches Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Diclofenac Patches, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Diclofenac Patches, Product Type & Application
2.7 Diclofenac Patches 麻豆原创 Competitive Situation and Trends
2.7.1 Diclofenac Patches 麻豆原创 Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Diclofenac Patches Players 麻豆原创 Share by Revenue
2.7.3 Global Diclofenac Patches 麻豆原创 Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Diclofenac Patches Retrospective 麻豆原创 Scenario by Region
3.1 Global Diclofenac Patches 麻豆原创 Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Diclofenac Patches Global Diclofenac Patches Sales by Region: 2019-2030
3.2.1 Global Diclofenac Patches Sales by Region: 2019-2024
3.2.2 Global Diclofenac Patches Sales by Region: 2025-2030
3.3 Global Diclofenac Patches Global Diclofenac Patches Revenue by Region: 2019-2030
3.3.1 Global Diclofenac Patches Revenue by Region: 2019-2024
3.3.2 Global Diclofenac Patches Revenue by Region: 2025-2030
3.4 North America Diclofenac Patches 麻豆原创 Facts & Figures by Country
3.4.1 North America Diclofenac Patches 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Diclofenac Patches Sales by Country (2019-2030)
3.4.3 North America Diclofenac Patches Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Diclofenac Patches 麻豆原创 Facts & Figures by Country
3.5.1 Europe Diclofenac Patches 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Diclofenac Patches Sales by Country (2019-2030)
3.5.3 Europe Diclofenac Patches Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Diclofenac Patches 麻豆原创 Facts & Figures by Country
3.6.1 Asia Pacific Diclofenac Patches 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Diclofenac Patches Sales by Country (2019-2030)
3.6.3 Asia Pacific Diclofenac Patches Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Diclofenac Patches 麻豆原创 Facts & Figures by Country
3.7.1 Latin America Diclofenac Patches 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Diclofenac Patches Sales by Country (2019-2030)
3.7.3 Latin America Diclofenac Patches Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Diclofenac Patches 麻豆原创 Facts & Figures by Country
3.8.1 Middle East and Africa Diclofenac Patches 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Diclofenac Patches Sales by Country (2019-2030)
3.8.3 Middle East and Africa Diclofenac Patches Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Diclofenac Patches Sales by Type (2019-2030)
4.1.1 Global Diclofenac Patches Sales by Type (2019-2024)
4.1.2 Global Diclofenac Patches Sales by Type (2025-2030)
4.1.3 Global Diclofenac Patches Sales 麻豆原创 Share by Type (2019-2030)
4.2 Global Diclofenac Patches Revenue by Type (2019-2030)
4.2.1 Global Diclofenac Patches Revenue by Type (2019-2024)
4.2.2 Global Diclofenac Patches Revenue by Type (2025-2030)
4.2.3 Global Diclofenac Patches Revenue 麻豆原创 Share by Type (2019-2030)
4.3 Global Diclofenac Patches Price by Type (2019-2030)
5 Segment by Application
5.1 Global Diclofenac Patches Sales by Application (2019-2030)
5.1.1 Global Diclofenac Patches Sales by Application (2019-2024)
5.1.2 Global Diclofenac Patches Sales by Application (2025-2030)
5.1.3 Global Diclofenac Patches Sales 麻豆原创 Share by Application (2019-2030)
5.2 Global Diclofenac Patches Revenue by Application (2019-2030)
5.2.1 Global Diclofenac Patches Revenue by Application (2019-2024)
5.2.2 Global Diclofenac Patches Revenue by Application (2025-2030)
5.2.3 Global Diclofenac Patches Revenue 麻豆原创 Share by Application (2019-2030)
5.3 Global Diclofenac Patches Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Acorda Therapeutics
6.1.1 Acorda Therapeutics Corporation Information
6.1.2 Acorda Therapeutics Description and Business Overview
6.1.3 Acorda Therapeutics Diclofenac Patches Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Acorda Therapeutics Diclofenac Patches Product Portfolio
6.1.5 Acorda Therapeutics Recent Developments/Updates
6.2 Endo International
6.2.1 Endo International Corporation Information
6.2.2 Endo International Description and Business Overview
6.2.3 Endo International Diclofenac Patches Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Endo International Diclofenac Patches Product Portfolio
6.2.5 Endo International Recent Developments/Updates
6.3 GlaxoSmithKline
6.3.1 GlaxoSmithKline Corporation Information
6.3.2 GlaxoSmithKline Description and Business Overview
6.3.3 GlaxoSmithKline Diclofenac Patches Sales, Revenue and Gross Margin (2019-2024)
6.3.4 GlaxoSmithKline Diclofenac Patches Product Portfolio
6.3.5 GlaxoSmithKline Recent Developments/Updates
6.4 Hisamitsu Pharmaceutical
6.4.1 Hisamitsu Pharmaceutical Corporation Information
6.4.2 Hisamitsu Pharmaceutical Description and Business Overview
6.4.3 Hisamitsu Pharmaceutical Diclofenac Patches Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Hisamitsu Pharmaceutical Diclofenac Patches Product Portfolio
6.4.5 Hisamitsu Pharmaceutical Recent Developments/Updates
6.5 Mylan
6.5.1 Mylan Corporation Information
6.5.2 Mylan Description and Business Overview
6.5.3 Mylan Diclofenac Patches Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Mylan Diclofenac Patches Product Portfolio
6.5.5 Mylan Recent Developments/Updates
6.6 Pfizer
6.6.1 Pfizer Corporation Information
6.6.2 Pfizer Description and Business Overview
6.6.3 Pfizer Diclofenac Patches Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Pfizer Diclofenac Patches Product Portfolio
6.6.5 Pfizer Recent Developments/Updates
6.7 Teikoku Seiyaku
6.6.1 Teikoku Seiyaku Corporation Information
6.6.2 Teikoku Seiyaku Description and Business Overview
6.6.3 Teikoku Seiyaku Diclofenac Patches Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Teikoku Seiyaku Diclofenac Patches Product Portfolio
6.7.5 Teikoku Seiyaku Recent Developments/Updates
6.8 IBSA Institut Biochimque
6.8.1 IBSA Institut Biochimque Corporation Information
6.8.2 IBSA Institut Biochimque Description and Business Overview
6.8.3 IBSA Institut Biochimque Diclofenac Patches Sales, Revenue and Gross Margin (2019-2024)
6.8.4 IBSA Institut Biochimque Diclofenac Patches Product Portfolio
6.8.5 IBSA Institut Biochimque Recent Developments/Updates
6.9 TEH SENG Pharmaceutical
6.9.1 TEH SENG Pharmaceutical Corporation Information
6.9.2 TEH SENG Pharmaceutical Description and Business Overview
6.9.3 TEH SENG Pharmaceutical Diclofenac Patches Sales, Revenue and Gross Margin (2019-2024)
6.9.4 TEH SENG Pharmaceutical Diclofenac Patches Product Portfolio
6.9.5 TEH SENG Pharmaceutical Recent Developments/Updates
6.10 ALLERGAN
6.10.1 ALLERGAN Corporation Information
6.10.2 ALLERGAN Description and Business Overview
6.10.3 ALLERGAN Diclofenac Patches Sales, Revenue and Gross Margin (2019-2024)
6.10.4 ALLERGAN Diclofenac Patches Product Portfolio
6.10.5 ALLERGAN Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Diclofenac Patches Industry Chain Analysis
7.2 Diclofenac Patches Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Diclofenac Patches Production Mode & Process
7.4 Diclofenac Patches Sales and 麻豆原创ing
7.4.1 Diclofenac Patches Sales Channels
7.4.2 Diclofenac Patches Distributors
7.5 Diclofenac Patches Customers
8 Diclofenac Patches 麻豆原创 Dynamics
8.1 Diclofenac Patches Industry Trends
8.2 Diclofenac Patches 麻豆原创 Drivers
8.3 Diclofenac Patches 麻豆原创 Challenges
8.4 Diclofenac Patches 麻豆原创 Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 麻豆原创 Size Estimation
10.1.3 麻豆原创 Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Companies Mentioned:

Acorda Therapeutics
Endo International
GlaxoSmithKline
Hisamitsu Pharmaceutical
Mylan
Pfizer
Teikoku Seiyaku
IBSA Institut Biochimque
TEH SENG Pharmaceutical
ALLERGAN

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.